PubRank

K Pantel

Author PubWeight™ 89.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000 6.98
2 Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci U S A 1999 3.74
3 In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000 3.57
4 Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997 2.28
5 Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997 2.03
6 Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 2000 1.99
7 Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1999 1.83
8 p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 1993 1.62
9 Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998 1.50
10 ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res 2001 1.48
11 p53 in non-small-cell lung cancer. J Natl Cancer Inst 1994 1.46
12 Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res 1999 1.43
13 MAGE-A gene expression pattern in primary breast cancer. Cancer Res 2001 1.34
14 Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer 2008 1.34
15 Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer 1999 1.33
16 Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991 1.31
17 Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 1996 1.22
18 Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 1994 1.18
19 RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci 2000 1.16
20 Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994 1.15
21 Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999 1.06
22 Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. Br J Cancer 2010 1.06
23 Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996 1.00
24 Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000 1.00
25 Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995 1.00
26 Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. Clin Cancer Res 1996 1.00
27 Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J Clin Oncol 2001 0.99
28 Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res 1999 0.99
29 Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells. Eur J Cancer 1996 0.98
30 The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence. Cancer 2001 0.97
31 Micrometastatic bone marrow involvement: detection and prognostic significance. Med Oncol 1999 0.96
32 Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urol Res 1994 0.94
33 A mathematical model of erythropoiesis in mice and rats. Part 1: Structure of the model. Cell Tissue Kinet 1989 0.94
34 Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance. World J Surg 1996 0.92
35 Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 2000 0.91
36 Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer. J Thorac Cardiovasc Surg 1995 0.90
37 Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study. Eur J Cardiothorac Surg 2002 0.90
38 Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells. Histochemistry 1993 0.90
39 Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 1996 0.90
40 Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 1996 0.90
41 Expression and prognostic significance of immunoregulatory molecules in esophageal cancer. Int J Cancer 1997 0.89
42 A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells. J Immunol Methods 1995 0.89
43 Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. BJU Int 2003 0.89
44 Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19. Int J Cancer 1997 0.88
45 Clinical significance of occult metastatic cells in bone marrow of breast cancer patients. Oncologist 2001 0.88
46 Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg 1999 0.87
47 Patterns of metastatic spread in early breast cancer. Breast 2013 0.84
48 p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci U S A 1999 0.84
49 Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J Natl Cancer Inst 1996 0.84
50 Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int J Oral Maxillofac Surg 1995 0.83
51 Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance. Eur J Cancer 1994 0.83
52 Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer. Int J Biol Markers 2006 0.83
53 Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat 1998 0.82
54 BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie? Cytotherapy 2005 0.82
55 Micrometastatic tumour cells in bone marrow in colorectal cancer. Lancet 1993 0.82
56 Biological characteristics of micrometastatic cancer cells in bone marrow. Cancer Metastasis Rev 1999 0.82
57 Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1998 0.82
58 A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Cytometry B Clin Cytom 2006 0.82
59 Ketone kinetics and D-(-)-3-hydroxybutyrate-induced inhibition of feeding in rats. Physiol Behav 1985 0.81
60 A mathematical model of erythropoiesis in mice and rats. Part 2: Stimulated erythropoiesis. Cell Tissue Kinet 1989 0.81
61 Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells. Clin Cancer Res 2000 0.81
62 Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11. Int J Cancer 1999 0.80
63 Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer. J Gastrointest Surg 2006 0.80
64 Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up. Eur Arch Otorhinolaryngol 2013 0.80
65 Immunocytochemical detection and characterization of individual micrometastatic tumor cells. Methods Mol Med 2001 0.79
66 Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 1995 0.79
67 Comparative immunocytochemical assessment of isolated carcinoma cells in lymph nodes and bone marrow of patients with clinically localized prostate cancer. Int J Cancer 1999 0.79
68 A mathematical model of erythropoiesis in mice and rats. Part 3: Suppressed erythropoiesis. Cell Tissue Kinet 1989 0.79
69 Supersensitive PSA-monitored neoadjuvant hormone treatment of clinically localized prostate cancer: effects on positive margins, tumor detection and epithelial cells in bone marrow. Eur Urol 1998 0.79
70 Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay. Int J Biol Markers 2003 0.79
71 A mathematical model of erythropoiesis suggests an altered plasma volume control as cause for anemia in aged mice. Exp Gerontol 1990 0.78
72 Hepatic handling of pancreatic glucagon and glucose during meals in rats. Am J Physiol 1984 0.78
73 Tumorigenic potential of apparently tumor-free lymph nodes. N Engl J Med 1999 0.78
74 Biological characteristics of micrometastatic carcinoma cells in bone marrow. Curr Top Microbiol Immunol 1996 0.77
75 Detection and relevance of immunohistochemically identifiable tumor cells in lymph nodes. Recent Results Cancer Res 2000 0.77
76 Micrometastases in bone marrow: prognostic indicators for pancreatic cancer. World J Surg 1999 0.77
77 Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am J Surg 1996 0.77
78 The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells. Int J Cancer 2000 0.76
79 Characterization of disseminated tumor cells. Semin Surg Oncol 2001 0.76
80 Epithelial tumour cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining. Eur J Cancer 1996 0.75
81 Staging of head and neck cancer. N Engl J Med 1995 0.75
82 Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer. Int J Biol Markers 2017 0.75
83 Evaluation of grafts for occult tumor cells. J Hematother 1994 0.75
84 [Expression of plakoglobin in bronchial carcinomas: incidence and significance for disease outcome]. Langenbecks Arch Chir Suppl Kongressbd 1996 0.75
85 Dissociation of epinephrine's hyperglycemic and anorectic effect. Physiol Behav 1985 0.75
86 [Tumor cells in the peripheral blood of patients with urothelial carcinoma of the bladder: detection and impact of circulating]. Urologe A 2014 0.75
87 [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer]. Pneumologie 2000 0.75
88 [The significance of regional lymphatic tumor cell dissemination in patients with resectable non-small cell bronchial carcinoma. Results of a prospective study]. Chirurg 1995 0.75
89 Metastasis formation in human solid tumors: phenotypic characteristics of early metastatic cells. Behring Inst Mitt 1992 0.75
90 Immunodiagnosis and immunotherapy of isolated tumor cells disseminated to bone marrow of patients with colorectal cancer. Tumori 1995 0.75
91 [Diagnosis and clinical significance of disseminated tumor cells in bone marrow]. Dtsch Med Wochenschr 2000 0.75
92 Diagnosis and therapeutic relevance of micrometastases. Recent Results Cancer Res 1998 0.75
93 [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma]. Zentralbl Chir 1996 0.75
94 [Prognostic factors in stage I of non-small-cell bronchial carcinoma]. Zentralbl Chir 1996 0.75
95 [Limits of surgery in patients with apparently localized bronchial carcinoma (pT1-3, pN0, M0)]. Langenbecks Arch Chir Suppl Kongressbd 1996 0.75
96 Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity. Int J Cancer 2001 0.75
97 Hunting down the seminal cells of clinical metastases. Immunol Today 1999 0.75
98 [Detection of circulating tumor cells from peripheral blood in prostate cancer]. Urologe A 2014 0.75
99 Keratin expression reveals mosaic differentiation in vaginal epithelium. Am J Obstet Gynecol 1993 0.75
100 [Simultaneous immunocytochemical detection of tumor cells in lymph nodes and in bone marrow of patients with resectable bronchial carcinomas]. Langenbecks Arch Chir Suppl Kongressbd 1998 0.75